INTRODUCTION
Infectious bursal disease virus (IBDV) causes an immunodepressive disease of chickens by destroying the B lymphocytes developing in the bursa of Fabricius (reviewed by Becht, 1980) . Maternal antibody, if present, will protect chickens from infection for the critical first few weeks after hatching. Although inactivated oil-emulsion whole IBDV vaccines are effective, their production is complicated by the expense of growing sufficient virus. Recombinant DNA technology offers the opportunity to simplify the production of the protective viral protein (VP) of IBDV, once it has been identified.
An Australian isolate of type 1 IBDV, designated 002/73, has been shown to be composed of two major structural proteins called VP-2b and VP-3 of Mr approximately 37K and 32K respectively and three other proteins of approximately 92K, 41K and 29K called VP-1, VP-2a and VP-4 respectively (Fahey et al., 1985a; Azad et al., 1987) . VP-2a is the precursor of VP-2b (Azad et al., 1987) . The 37K and 41K proteins are probably analogous to VP-2 (Mr 40K to 42K) and VP-X (Mr 47K) respectively of the Cu-1 isolate of type 1 IBDV described by Dobos (1979) and Miiller & Becht (1982) . This is particularly likely as the Mr values calculated from the amino acid sequences of VP-2a and VP-2b (Hudson et al., 1986) show them to be higher than those estimated from Laemmli discontinuous SDS-polyacrylamide gels (Fahey et al., 1985a) .
Analysis of the antibody response of chickens to IBDV by Western blotting revealed that VP-3 was recognized as a major immunogen, particularly during the early phase of the antibody response (Fahey et al., 1985a) . Immunization of chickens with denatured viral proteins electroeluted from SDS-polyacrylamide gels indicated that VP-3 had an epitope(s) capable of inducing virus-neutralizing (VN) antibodies, which could passively protect young chickens from infection (Fahey et al., 1985b) . However, these experiments were undertaken using viral proteins which had been denatured with SDS.
Data from studies with mouse monoclonal antibodies that neutralize IBDV (Becht et al., 1988; K. J. Fahey et al., in preparation) indicated that at least one epitope important in virus neutralization was destroyed by treatment with SDS. Several of these VN monoclonal antibodies failed to react on Western blotting of viral proteins separated by SDSpolyacrylamide gel electrophoresis.
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The observation that IBDV became partially disrupted after several months storage at -20 °C and released soluble VP-2a, VP-2b and VP-3 provided a means of obtaining these viral proteins in their native form. Monoclonal antibodies specific for VP-3 were found to remove soluble VP-3 efficiently, as well as aggregates of viral proteins and whole virus from the supernatant of ultracentrifuged (pelleted) virus preparations. A series of experiments performed using native VP-2a/2b has located another, and possibly the major, VN and protective epitope of IBDV. A similar conclusion was reached by using VN monoclonal antibodies to screen portions of the large segment of the IBDV genome expressed in Escherichia coli (Azad et al., 1987) and by immunoprecipitating detergent-solubilized radiolabelled viral proteins (Brecht et al., 1988) .
METHODS
Animals. White Leghorn chickens were supplied by the CSIRO Specified-Pathogen Free (SPF) Poultry Unit, Maribyrnong, Victoria, Australia and transferred into flexible-walled plastic isolators at hatching. The chickens were fed methylbromide-fumigated feed and acidified water ad libitum. Adult rabbits were supplied by the CSIRO McMaster Laboratory Farm, Badgery's Creek, N.S.W., Australia.
Virus. A type 1 Australian isolate of IBDV, designated 002/73, was propagated, titrated for infectivity in young chickens and purified as described previously (Fahey et al., 1985a. b) . The 002/73 virus was used to vaccinate chickens and was also used as the antigen in Western blotting analysis of sera.
The tissue culture-adapted strain of IBDV, GTI01, initially provided by Arthur Webster Pty Ltd, Sydney, Australia, was propagated in chick embryo fibroblasts and used in the in vitro virus neutralization assay.
Preparation of native . Purified virus was collected after banding on a continuous 25 to 50~ (w/v) CsC1 gradient (Fahey et al., 1985a) , dialysed against 0.075 M-NaCI for 4 to 6 h at 4 °C and then stored at -20 °C. After storage for longer than 1 month, the virus was pelleted by centrifugation at 28000 r.p.m, for 2 h in an SW56 rotor (Beckman). The supernatant was collected and passed through an adsorption column containing mouse monoclonal antibody (code no. l-l-l), which was specific for the VP-3 protein of IBDV by Western blotting. The affinity column was prepared by reacting 25 mg of purified monoclonal IgG antibody with 2 ml of Tresyl-activated Sepharose (Pharmacia) according to the manufacturer's instructions. The ultracentrifuged supernatant was passe d through the column twice, after which only VP-2b and occasionally the related VP-2a could be detected by silver staining or Western blotting with a polyvalent chicken antiserum (Fig. 1) . The Mr of the isolated VP-2a and VP-2b appeared identical to those of intact IBDV determined by SDS-PAGE. The concentration of viral protein was determined by the method of Lowry et al. (1951) .
For in vivo studies the solution of native VP-2a/2b or whole virus was reacted with fl-propiolactone. Eighteen parts of viral protein were mixed with 1 part of 0.5 M-Na3PO4 and carefully layered under 1 part of 2~ (v/v) flpropiolactone (Sigma). The solutions were mixed gently and transferred to a sterile tube, avoiding splashing. The solution was incubated at 37 °C for 1 h with frequent stirring, then transferred to another sterile tube and then reincubated for a further I h. Finally the solution was transferred to another tube and incubated overnight at 4 °C. The sterility of the fl-propiolactone-treated solutions was assessed by inoculating SPF chickens intraocularly (i.o.) with 50 pl of inactivated protein and examining, by ELISA, the bursae of Fabricius of the chickens 4 days later for the presence of viral antigen.
Antisera to whole IBDV or native . Six-to 10-week-old SPF chickens were inoculated i.o. with 002/73 and bled at 0, 3, 5, 7, 10 and 14 days after infection. Other SPF chickens were injected intramuscularly (i.m.) with 100 ~tg of inactivated native VP-2a/2b emulsified in an equal volume of Freund's complete adjuvant (Difco), then with another 100 ~tg of protein in Freund's incomplete adjuvant 4 weeks later. The chickens were bled at intervals thereafter and the serum collected was stored at -20 °C. Rabbits were immunized with native VP-2a/2b in a similar manner.
Virus neutralization and inhibition micro-assays. The VN antibody micro-assay described by Fahey et al. (1985b) was used to quantify the response of both chickens and rabbits. The ability of VP-2a/2b and whole virus to inhibit VN activity was quantified by incubating 25 ~1 of serial dilutions of heat-inactivated antisera with 25 ftl of a 200 ~tg/ml solution of the 002/73 virus or VP-2a/2b at 37 °C for 1 h. The VN activity remaining in the sera was then assayed as before using the tissue culture-adapted strain of IBDV (GTI01).
ELISAsfor attti-lBDV antibody and 1BDVantigen. The ELISAs employed to quantify chicken antibodies and viral antigen in homogenates of infected bursae were those described previously (Fahey et al., 1985a) .
Preparation of affinity columns of viral proteins and adsorption of chicken antisera. VP-2a, VP-2b and VP-3 were electroeluted from SDS-PAGE gels of whole IBDV, dialysed against distilled H20 and bound to Affi-Gel 10 (BioRod) as described previously (Fahey et aL, 1985 b) . Antiserum from immunized chickens was adsorbed by running 0.25 ml of serum into the columns and collecting the first 2 ml eluted with phosphate-buffered saline (PBS). The affinity columns were reactivated after each adsorption by passing 5 ml of I M-propionic acid through the column followed by 20 ml of PBS. One serum was adsorbed three times on the VP-3 column by running the 2 ml of eluted
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Fig. 1. Analysis of intact IBDV (lanes 1) and the supernatant of ultracentrifuged IBDV before (lanes 2) and after (lanes 3) passage through a monoclonal antibody adsorption column specific for VP-3. Bands on SDS-PAGE gels were visualized by (a) silver staining or (b) Western blotting with polyvalent hyperimmune chicken anti-IBDV serum.
antibody from the first adsorption column slowly through the reactivated column and eluting it with a further 2 ml of PBS. The 4 ml of antibody solution was again run slowly through the reactivated column and eluted with a further 2 ml of PBS, giving a final dilution of 1 : 24 of the original 0.25 ml of serum. lmmunoprecipitation of native VP-2a/2b. Aliquots (100 ~tl) of a 30 ~ (w/v) suspension of Protein A-Sepharose 4B (Pharmacia) were reacted with 300 ~tl of a 1 : 100 dilution of rabbit IgG anti-chicken Ig for 1 h, washed three times with PBS by centrifugation at 12000 r.p.m, for 3 rain in a microfuge (Hettich). The complex was reacted with 60 ~tl of chicken anti-IBDV serum for 1 h and washed a further three times. The complexed Sepharose was then blocked with a 1:20 dilution of normal rabbit serum for 30 rain. Finally the complexed Sepharose was mixed with 150 ~tl of the native VP-2a/2b (200 ~tg/ml) for 2 h, with constant mixing. The Sepharose was again washed with PBS following the careful removal of the supernatant containing the unbound VP-2a/2b. The washed pellet was boiled with 3~o SDS prior to PAGE and Western blotting with polyvalent chicken anti-IBDV serum.
PAGEand Western blotting ofviralproteins. Viral proteins and immunoprecipitates were analysed on 10~ (w/v) polyacrytamide slab gels using the discontinuous SDS gel system of Laemmli (1970) . The separated proteins were then transferred onto nitrocellulose paper by the Western blotting technique described by Burnette (i981) and reacted with chicken antisera as described by Fahey et aL ~1985a, b) .
Passive protection of chickens with anti-371£/41K antibody. Groups of 3-day-old SPF chickens were each injected intraperitoneally (i.p,) with 1 ml of immune serum and challenged i.o. 6 h later with 100 CIDso of IBDV (002/73). The chickens were subjected to post-mortem examination 3 days later and the titres of circulating antibody and viral antigen in 10% (w/v) homogenates of the bursae of Fabricius were assessed by ELISA.
RESULTS

Adsorption of chicken antisera with the denatured structural proteins of IBD V
To study the specificity of VN antibodies, antisera from chickens vaccinated with live IBDV were passed through affinity columns prepared from VP-2a, VP-2b and VP-3 which had been electroeluted from SDS-PAGE gels. The VP-3 column, but not the VP-2a or VP-2b columns, Table I a) against whole virus prior to and following adsorption with affinity columns of viral protein eluted from SDS-PAGE gels. Lanes 1, original serum; lanes 2, after VP-3 column; lanes 3, after VP-2b column; lanes 4, after VP2a column. (Fig. 2) , depending on the initial titre of the sera. However, passing the i m m u n e chicken sera through the VP-3 column either had no effect or only reduced the V N titre by onefold or 5 0~ (Table 1 a) . Passing the a n t i -I B D V sera through columns containing denatured VP-2a or VP-2b also failed to decrease the V N titre of the sera. To ascertain whether the limited capacity of the VP-3 affinity column restricted the magnitude of the decrease in VN titre, one low-titre serum was passed through it three times. The post-adsorption serum had no Western blotting antibody to VP-3, but retained 50 ~ or more of the VN and ELISA titres of the original serum (Table I b) .
Immunoprecipitation of native VP-2b with antisera specific for VP-3 by Western blotting
Following infection with IBDV, VN antibody first appeared in serum collected on day 5 and increased dramatically thereafter (Table 2) , and antisera collected from days 7 to 14 postinfection specifically reacted with VP-3 on Western blots (Fig. 3 a) . Since removal of antibody able to react with VP-3 did not reduce the titre of VN antibody substantially, specificities for native viral proteins were sought. Immunoprecipitation studies using a preparation of native VP-2b, which did not contain detectable levels of VP-2a, showed that antisera collected on days 7, 10 and 14 post-infection precipitated VP-2b with increasing efficiency (Fig. 3b) until by day 10 all the available VP-2b was specifically precipitated. Unfortunately, pure VP-3 in its native form was not available for parallel studies.
Virus neutralization inhibition studies with native VP-2a/2b
To determine whether the native VP-2 could inhibit VN antibody activity, four antisera from chickens vaccinated with IBDV were serially diluted and incubated with an equal volume of either whole virus or native VP-2a/2b protein. These antisera were then assayed for V N activity against the tissue culture-adapted virus (Table 3 ). The solution of VP-2a/2b protein effectively inhibited the VN activity of the antisera and on one occasion was as effective as whole virus (Table 3) . 
Antibody responses of SPF chickens or rabbits to native VP-2a/2b
Two 8-week-old SPF chickens and two adult rabbits were vaccinated on two occasions with/?-propiolactone-inactivated VP-2a/2b emulsified in adjuvant. The chickens and rabbits had good VN antibody responses by 3 weeks or 4 weeks after the first injection respectively, and the titre increased following the second injection of protein (Table 4) .
Although the first Needs from both the chickens and the rabbits contained VN antibodies, these did not react with viral proteins on Western blots. However, the sera obtained from both chickens and one of the two rabbits after the second injection of protein specifically detected VP-2a and VP-2b. Both chicken sera reacted more strongly than the rabbit serum (data not shown).
A dose-response study was undertaken to compare #-propiolactone-inactivated whole IBDV and VP-2a/2b. Groups of 15 to 18 8-week-old SPF chickens were injected i.m. with 0.5 ml containing 0.625, 2.5, 10 or 40 gg of protein emulsified in an equal volume of Freund's incomplete adjuvant. The magnitude and kinetics of the ELISA antibody responses obtained in the chickens injected with 2.5 ~tg of whole virus were comparable to those in chickens injected with 40 gg of native VP-2a/2b.
Passive protection of young chickens with antibody to VP-2a and VP-2b
To determine whether the antibody induced by native VP-2 could protect against disease, groups of 3-day-old chickens were injected i.p. with anti-VP-2a/2b sera from the two immunized chickens reported in Table 4 . When challenged 6 h later, all the recipient chickens were completely protected against an i.o. challenge infection with 100 CIDs0 of virulent IBDV (002/73). The chickens had significant levels of circulating antibody detectable by ELISA at post mortem 3 days post-infection, but no evidence of virus replication in their bursae of Fabricius (Table 5) , Table 5 . Passive protection of chickens with antiserum to I~P-2a/2b Mean ELISA titter"
Viral antigen
Residual antibody Antiserum* in bursae in circulation 1 < 1 8990 2 < 1 2710 Nil > 128 <2 1479 * Antisera were obtained at 6 weeks post-immunization from chickens 1 and 2 shown in Table 4 . t Groups of seven 3-day-old chickens were injected i.p. with 1 ml of immune serum and challenged i.o. 6 h later with 100 CID5o of IBDV (002/73). The chickens were examined post mortem 3 days after the challenge.
DISCUSSION
Previous studies on the antibody response of SPF chickens to IBDV identified an immunogenic epitope(s) on the viral protein VP-3. This epitope(s) was stable following boiling in the presence of SDS and reacted on Western blots with immune sera (Fahey et al., 1985a) . Similarly, denatured VP-3 electroeluted from SDS-PAGE gels induced in mature chickens VN antibodies that could passively protect young chicks (Fahey et al., 1985b) . Identification of epitopes on native viral proteins was hampered at that time by an inability to dissociate purified intact virus particles without denaturing the structural proteins.
Adsorption of VN antisera with affinity columns of the denatured structural proteins of IBDV indicated that only VP-3 reduced the VN titre of chicken antisera, but then by rio more than one twofold dilution. Even repeated adsorption of a serum with VP-3, which removed all Western blotting activity from the serum, did not reduce the VN titre further. These experiments indicated that there was at least one other epitope, probably a conformational epitope, capable of inducing VN antibody.
Insufficient amounts of VP-1 and VP-4 could be obtained by SDS-PAGE and electroelution to study their role as immunogens, although it has been noted that they are rarely detected on Western blots, even with hyperimmune serum (Fahey et al., 1985a) .
Subsequent studies showed that the IBDV partially dissociated upon storage at -20 °C, particularly in the presence of the CsC1 remaining after the final step oi ~ the purification procedure. By passing the supernatants of ultracentrifuged (pelleted) virus through affinity columns of monoclonal antibody specific for VP-3, a solution of VP-2b and its precursor VP-2a could be obtained which was free of all other viral proteins as judged by Coomassie Brilliant Blue and silver staining of SDS-PAGE gels. The preparations of VP-2a/2b were also free of VP-1, VP-3 and VP-4 as assessed by Western blotting with a hyperimmune polyvalent antiserum containing antibodies to all viral proteins.
Sera collected early in the immune response of chickens to live IBDV, which appeared specific for VP-3 by Western blotting, were found to contain antibodies that could specifically immunoprecipitate native VP-2b. The VN activity of these chicken antisera could also be inhibited by incubation with native VP-2a/2b. In some instances the reduction in titre was comparable to that achieved with the same amount (protein concentration) of whole virus.
These experiments indicate that native VP-2a/2b contained an epitope that induced VN antibodies, but which could not withstand boiling in SDS. This was further supported by the finding that native VP-2a/2b, but not denatured VP-2a or VP-2b, could remove VN activity from immune chicken serum. Recent deletion-expression studies on VP-2 in E. coli support this conclusion and have shown that the epitope for the VN monoclonal antibody is located near the middle of VP-2b (Azad et al., 1987) . In addition, immunoprecipitation studies with VN monoclonal antibodies and solubilized viral proteins have detected a conformation-dependent epitope on VP-2 (Becht et al., 1988; K. J. Fahey et al., unpublished data) .
When chickens and rabbits were immunized with fl-propiolactone-inactivated native VP2a/2b in adjuvant, they produced VN antibodies, whereas chickens injected with VP-2a/2b that had been boiled with SDS did not produce VN antibodies (data not shown). Interestingly, the antisera obtained after the first immunization with native VP-2a/2b did not react with whole virus on Western blots, suggesting that the predominant response was to one (or more) conformational epitopes on the protein. A comparative study in chickens showed that the separated VP-2a/2b was 10 to 20 times less immunogenic than whole virus particles, although the reason for this requires further study. Nevertheless, susceptible chickens inoculated with chicken antisera to native VP-2a/2b were passively protected against infection with virulent IBDV.
The validity of these findings with native VP-2a/2b depends largely on the purity of the isolated viral proteins. To that end it was demonstrated by silver staining that VP-1, VP-3 and VP-4 were absent from the solution of VP-2a/2b. Western blotting also failed to detect proteins other than VP-2a and VP-2b in the solution. The failure of the immunized chickens or rabbits to produce antibodies to VP-3, which hitherto have been readily detectable by Western blotting (Fahey et al., 1985a) , supports the absence of VP-3 from preparations of VP-2a/2b. The comparable efficacy of isolated VP-2a/2b and whole virus in removing VN activity from immune chicken serum also suggested that the relevant epitope(s) reside on VP-2a/2b.
The literature contains reports of VN antibody responses to sequential determinants defined by short peptide sequences (Bittle et al., 1982; Lerner, 1982; Cohen et al., 1984) and to conformational determinants made up of discontinuous peptide sequences (Cohen et al., 1986; Dyall-Smith et al., 1986; Jim6nez et al., 1986; Samson et al., 1986) . The epitope previously identified on VP-3 would seem to be of the first type, while the epitope now identified on VP-2 would be of the second type. In terms of relative immunogenicity, as defined by the VN antibody response to approximately comparable amounts of protein [50 ~tg twice of VP-3 protein (Fahey et al., 1985b) and 100 btg twice of VP-2a/2b protein], VP-2a/2b would appear to be a much stronger immunogen than VP-3. W. N. Burnette & V. Mar (poster presentation, Cold Spring Harbor, September 1985) reported that non-denatured 40K viral protein, purified by column chromatography (personal communication), elicited in rabbits VN antibodies which specifically detected denatured 40K viral protein transferred by Western blotting. Using a similar protocol we have been unable to separate VP-2a or VP-2b of the Australian IBDV from VP-3, except by finally removing the VP-3 with anti-VP-3-specific monoclonal antibody.
From previous Western blotting studies on the antibody response to IBDV and the present studies with native VP-2a/2b, a subunit vaccine to IBDV would need to contain the conformational epitope on VP-2a/2b and possibly the sequential epitope on VP-3, particularly if the latter contributes to the folding of VP-2a/2b.
